Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
- 1 December 2017
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 214 (6) , 1082-1088
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?Annals of Surgical Oncology, 2017
- Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical OutcomesAnnals of Surgical Oncology, 2016
- Can axillary node dissection be safely omitted in the elderly? A retrospective study on axillary management of early breast cancer in older womenInternational Journal of Surgery, 2016
- Tumor characteristics and therapy of elderly patients with breast cancerJournal of Cancer Research and Clinical Oncology, 2016
- Axillary Dissection Versus No Axillary Dissection in Older Patients With T1N0 Breast CancerAnnals of Surgery, 2012
- Treatment of breast cancer in the elderly: A prospective, population-based Swiss studyJournal of Geriatric Oncology, 2012
- Determinants of outcome in elderly patients with positive sentinel lymph nodesThe American Journal of Surgery, 2011
- Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancerBreast Cancer Research and Treatment, 2011
- Can Sentinel Node Biopsy Be Avoided in Some Elderly Breast Cancer Patients?Annals of Surgery, 2009
- Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by IrradiationNew England Journal of Medicine, 2002